To smell autoimmunity: Anti-P-ribosomal autoantibodies, depression, and the olfactory system

Journal of Autoimmunity

Volumn 28, Issue 2-3, 2007, Pages 165-169

  Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoantibodies; CNS lupus; Depression; Olfaction; Psychosis

Indexed keywords

AUTOANTIBODY; FLUOXETINE; IMMUNOGLOBULIN; P RIBOSOMAL AUTOANTIBODY; UNCLASSIFIED DRUG;

AUTOIMMUNITY; CLINICAL FEATURE; DEPRESSION; HISTOPATHOLOGY; HUMAN; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MENTAL DISEASE; NEUROLOGIC DISEASE; NONHUMAN; OLFACTORY DISCRIMINATION; OLFACTORY SYSTEM; PATHOGENICITY; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; CENTRAL NERVOUS SYSTEM; DEPRESSIVE DISORDER; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; OLFACTION DISORDERS; PHOSPHOPROTEINS; RIBOSOMAL PROTEINS;

EID: 34247593693     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.02.012     Document Type: Review

References (40)

1. Zandman-Goddard G, Chapman J, Shoenfeld Y. Explosion of autoantibodies involved in neuropsychiatric. SLE and antiphospholipid syndrome. Seminar Arthritis Rheum, in press.
2. Ebert T., Chapman J., and Shoenfeld Y. Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality?. Lupus 14 (2005) 571-575
3. Gerli R., and Caponi L. Anti-ribosomal P protein antibodies. Autoimmunity 38 (2005) 85-92
4. Sun K.H., Tang S.J., Chen C.Y., Lee T.P., Feng C.K., Yu C.L., et al. Monoclonal ribosomal P autoantibody inhibits the expression and release of IL-12, TNF-α and iNOS in activated RAW macrophage cell line. J Autoimmun 24 (2005) 135-143
5. Nagai T., Arinuma Y., Yanagida T., Yamamoto K., and Hirohata S. Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes. Arthritis Rheum 52 (2005) 847-855
6. Karassa F.B., Afeltra A., Ambrozic A., Chang D.M., De Keyser F., Doria A., et al. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 54 (2006) 312-324
7. do Nascimento A.P., Viana Vdos S., Testagrossa Lde A., Leon E.P., Borda E.F., Barros R.T., et al. Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis. Arthritis Rheum 54 (2006) 1568-1572
8. Takeda I., Iwadate H., Sugisaki K., Takahashi A., Nogae S., Kanno T., et al. Anti-ribosimal P antibodies are associated with nephritis, vascular thrombosis and lymphocytopenia in patients with systemic lupus erythematosus. Fukushima J Med Sci 51 (2005) 11-18
9. Bonfa E., Golombek S.J., Kaufman L.D., Skelly S., Weissbach H., Brot N., et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. New Engl J Med 317 (1987) 265-271
10. Shovman O., Gilburd B., Barzilai O., Shinar E., Larida B., Zandman-Goddard G., et al. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann NY Acad Sci 1050 (2005) 380-388
11. Zhang W., and Reichlin M. Production and characterization of a human monoclonal anti-idiotype to anti-ribosomal P antibodies. Clin Immunol 114 (2005) 130-136
12. Katzav A, Solodeev I, Brodsky O, Chapman J, Pick CG, Blank M, et al. Autoimmune depression: anti-P-ribosomal induce depression in mice via the limbic system. Arthritis Rheum, in press.
13. Zueger M., Urani A., Chourbaji S., Zacher C., Roche M., Harkin A., et al. Olfactory bulbectomy in mice induces alterations in exploratory behavior. Neurosci Lett 374 (2005) 142-146
14. Satoh S., Morita N., Matsuzaki I., Konishi T., Nakano T., Minoshita S., et al. Relationship between odor perception and depression in the Japanese elderly. Psychiatry Clin Neurosci 50 (1996) 2781-2785
15. Komori T., Fujiwara R., Tanida M., Nomura J., and Yokoyama M.M. Effects of citrus fragrance on immune function and depressive states. Meuroimmunomodulation 2 (1995) 174-180
16. Yoshio T., Hirata D., Onada K., Nara H., and Minota S. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus. J Rheumatol 32 (2005) 34-39
17. Zivadinov R., Zorzon M., Monti Bragadin L., Pagliarto G., and Cazzato G. Olfactory loss in multiple sclerosis. Meurol Scio 168 (1999) 127-130
18. Sherer Y., Gorstein A., Fritzler M.J., and Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Seminar Arthritis Rheum 34 (2004) 501-537
19. Strous R.D., and Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmunity 27 (2006) 71-80
20. Mahler M., Kessenbrock K., Szmyrka M., Takasaki Y., Garcia-De La Torre I., Shoenfeld Y., et al. International multicenter evaluation of autoantibodies to ribosomal P proteins international multicenter evaluation of autoantibodies to ribosomal P proteins. Clin Vaccine Immunol 13 (2006) 77-83
21. Toubi E., and Shoenfeld Y. The biological aspects of anti-P-Ribosomal Protein autoantiobodies. Autoimmunity Rev 6 (2007) 119-125
22. Koren E., Schnitz W., and Reichlin M. Concomitant development of chronic active hepatitis and antibodies to ribosomal P proteins in a patient with SLE. Arthritis Rheum 36 (1993) 1325-1328
23. Hulsey M., Goldstein R., Scully L., Surbeck W., and Reichlin M. Anti-ribosomal P antibodies in SLE: a case-control study correlating hepatic and renal disease. Clin Immunol Immunopathol 74 (1995) 252-256
24. Ohira H., Takiguchi J., Rai T., Abe K., Yokokawa J., Sato Y., et al. High frequency of anti-ribosomal P antibody in patients with systemic lupus erythematosus-associated hepatitis. Hepatol Res 28 (2004) 137-139
25. Masardo L., Burgos P., Martinez M.E., Perez R., Clavo M., Barros J., et al. Anti-ribosomal P protein antibodies in Chilean SLE patients: no association with renal disease. Lupus 11 (2002) 379-383
26. Shoenfeld Y., Nahum A., Korczyn A.D., Dano M., Rabinowitz R., Beilin O., et al. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 12 (2003) 436-442
27. Strous R.D., and Shoenfeld Y. To smell the immune system: olfaction, autoimmunity and brain involvement. Autoimmun Rev 6 (2006) 54-60
28. Soares J.C., and Mann J.J. The functional neuroanatomy of mood disorders. J Psychiatr Res 31 (1997) 393-432
29. Malberg J.E., and Schechter L.E. Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs. Curr Pharm Des 11 (2005) 145-155
30. Byrum C.E., Ahearn E.P., and Krishnan K.R. A neuroanatomic model for depression. Prog Neuropsychopharmacol Biol Psychiatry 23 (1999) 175-193
31. Nugent A.C., Milham M.P., Bain E.E., Mah L., Cannon D.M., Marrett S., et al. Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry. Neuroimage 30 (2006) 485-497
32. Pause B.M., Miranda A., Goder R., Aldenhoff J.B., and Ferstl R. Reduced olfactory performance in patients with major depression. J Psychiatr Res 35 (2001) 271-277
33. McCaffrey R.J., Duff K., and Solomon G.S. Olfactory dysfunction discriminates probable Alzheimer's dementia from major depression: a cross-validation and extension. J Neuropsychiatry Clin Neurosci 12 (2000) 29-33
34. Song C., and Leonard B.E. The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29 (2005) 627-647
35. Peters J.M., Hummel T., Kratzsch T., Lotsch J., Skarke C., and Frölich L. Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques. Am J Psychiatry 160 (2003) 1995-2002
36. Ward C.D., Hess W.A., and Calne D.B. Olfactory impairment in Parkinson's disease. Neurology 33 (1983) 943-946
37. Kopala L.C., Good K.P., Morrison K., Bassett A.S., Alda M., and Honer W.G. Impaired olfactory identification in relatives of patients with familial schizophrenia. Am J Psychiatry 158 (2001) 1286-1290
38. Mendelovic S., Brocke S., Shoenfeld Y., Ben-Bassat M., Meshorer A., Bakimer R., et al. Induction of a SLE-like disease in mice by a common anti-DNA idiotype. Proc Nat Acad Sci (USA) 85 (1988) 2260-2264
39. Shoenfeld Y. Anti-DNA idiotypes: from induction of disease to novel therapeutical approaches. Immunol Lett 100 (2005) 73-77
40. Shoenfeld Y. Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J 8 (1994) 1296-1301